PMC:7558914 / 24439-24617
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T29 | 21-28 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T30 | 21-28 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T31 | 62-69 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T32 | 62-69 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
594 | 89-96 | Species | denotes | patient | Tax:9606 |
595 | 123-130 | Species | denotes | patient | Tax:9606 |
601 | 21-28 | Chemical | denotes | heparin | MESH:D006493 |
602 | 62-69 | Chemical | denotes | heparin | MESH:D006493 |
603 | 151-161 | Chemical | denotes | creatinine | MESH:D003404 |
620 | 133-141 | Disease | denotes | bleeding | MESH:D006470 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T155 | 0-178 | Sentence | denotes | Low-molecular-weight heparin is preferred over unfractionated heparin in order to reduce patient contact (depending on the patient’s bleeding risk and creatinine clearance) [36]. |